A team of UK biotech experts from MALDI ToF believe it is close to delivering a sophisticated and affordable testing technology that will complement the binary COVID-19 tests currently in use.

Continue Reading A team of UK biotech experts from MALDI ToF believe it is close to delivering a sophisticated and affordable testing technology that will complement the binary COVID-19 tests currently in use.